Healthcare has agreed to buy a U.S.-based healthcare
data provider for $635 million to boost research and
development, the company said on Wednesday, a month after it
acquired the new molecules division of Germany's Bayer's
.
Tuesday, 15 May 2012
UPDATE 1-India's Piramal Healthcare to buy U.S. firm to boost R&D
MUMBAI, May 16 (Reuters) - Indian drugmaker Piramal
Healthcare has agreed to buy a U.S.-based healthcare
data provider for $635 million to boost research and
development, the company said on Wednesday, a month after it
acquired the new molecules division of Germany's Bayer's
. 
Healthcare has agreed to buy a U.S.-based healthcare
data provider for $635 million to boost research and
development, the company said on Wednesday, a month after it
acquired the new molecules division of Germany's Bayer's
.
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment